Jon Tremmel - EnteroMedics Consultant To The CEO and Director
CEO
Mr. Jon T. Tremmel is Independent Director of EnteroMedics Inc., since January 28, 2009. Mr. Jon T. Tremmel, has served as one of our directors since January 2009. Mr. Tremmel was retired and acting as an independent consultant since 2007. Over the course of his career at Medtronic, Inc., Mr. Tremmel served in a variety of senior management positions, including President of the Neurological Division from 2003 to 2007, President of the Physio Control Division, President of the Tachyarrhythmia Management Division and President of the Interventional Vascular Division since 2009.
| Age | 69 |
| Tenure | 15 years |
| Phone | 651-634-3003 |
| Web | http://www.enteromedics.com |
EnteroMedics Management Efficiency
The company has return on total asset (ROA) of (48.42) % which means that it has lost $48.42 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (146.32) %, meaning that it created substantial loss on money invested by shareholders. EnteroMedics' management efficiency ratios could be used to measure how well EnteroMedics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | CEO Age | ||
| Ivan Menezes | Diageo PLC ADR | 65 | |
| Anand Kripalu | Diageo PLC ADR | 59 | |
| Carlos Brito | Anheuser Busch Inbev | 60 | |
| Brendan Whitworth | Anheuser Busch Inbev | 45 | |
| Xiaobin Liu | Gulf Resources | 56 | |
Management Performance
| Return On Equity | -146.32 | |||
| Return On Asset | -48.42 |
EnteroMedics Leadership Team
Elected by the shareholders, the EnteroMedics' board of directors comprises two types of representatives: EnteroMedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EnteroMedics. The board's role is to monitor EnteroMedics' management team and ensure that shareholders' interests are well served. EnteroMedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EnteroMedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jon Tremmel, Consultant To The CEO and Director | ||
| Peter Delange, Senior Vice President - Operations and Business Development | ||
| Scott Youngstrom, CFO, Chief Compliance Officer | ||
| Dan Gladney, CEO and President and Director | ||
| Nicholas Teti, Independent Director | ||
| Carl Goldfischer, Independent Director | ||
| Catherine Friedman, Independent Director | ||
| Michael Mashaal, Director | ||
| Lori McDougal, Director | ||
| Gary Blackford, Director | ||
| Nick Ansari, Senior Vice President - Sales | ||
| Scott Shikora, Executive Vice President - Medical Affairs and Chief Medical Officer | ||
| Anthony Jansz, Director | ||
| Adrianus Donders, Sr. VP of Research and Advanced Devel. | ||
| Katherine Tweden, Co-Founder and VP of Clinical and Regulatory | ||
| Mark Knudson, Founder and Executive Chairman | ||
| Gregory Lea, CFO, Principal Accounting Officer, Chief Compliance Officer and Secretary | ||
| Paul Hickey, Senior Vice President - Marketing and Reimbursement | ||
| Bobby Griffin, Independent Director | ||
| Tonya Dowd, Vice President - Reimbursement | ||
| Naqeeb Ansari, Senior Vice President - Sales |
EnteroMedics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EnteroMedics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -146.32 | |||
| Return On Asset | -48.42 | |||
| Current Valuation | 5.39 M | |||
| Shares Outstanding | 14.57 M | |||
| Shares Owned By Insiders | 6.79 % | |||
| Shares Owned By Institutions | 2.64 % | |||
| Number Of Shares Shorted | 1.13 M | |||
| Price To Earning | (0.32) X | |||
| Price To Book | 0.45 X | |||
| Price To Sales | 52.22 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EnteroMedics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EnteroMedics' short interest history, or implied volatility extrapolated from EnteroMedics options trading.
Pair Trading with EnteroMedics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnteroMedics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnteroMedics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in EnteroMedics Stock
If you are still planning to invest in EnteroMedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EnteroMedics' history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |